Rising yields in the US continued to support the greenback as it outperformed the and .
The pound came under additional selling pressure as the vaccine conflict between the EU and the U.K. has been growing since AstraZeneca (NASDAQ:) informed Brussels it wouldn’t deliver the number of vaccine shots it had promised for the first quarter.
The EU is ready to block exports of the AstraZeneca vaccine to the U.K. until the company fulfills its delivery obligations to the bloc.
EU leaders will meet in Brussels on Thursday and Friday to discuss the vaccine restriction plan among other topics.
While the EU looks to be struggling to vaccinate its population against Covid-19 the fundamental forecast for the euro is bearish.
Looking at the technical picture we pencil in a lower target at around 1.18 and it will be interesting for euro bears whether a significant break below that crucial support level will lead to a slide towards 1.16. On the upper side, the recent resistance at 1.20 remains a focus of interest and we will wait for a bullish break above that level and further 1.2060 in order to expect higher targets at 1.2170 or 1.2250.
The cable remained within in its recent sideways range as both the Federal Reserve and the Bank of England retain their current course for monetary policy. While the current vaccine battle between the U.K. and EU weighs on the exchange rate, the fundamental forecast for the pound remains neutral.
Technically, we continue to watch out for price breaks either above 1.40 or below 1.3780.
On the economic docket this week we will have various central bankers’ speeches, the U.K. figures on Wednesday and the EU summit in Brussels towards the end of the week.
Disclaimer: All trading ideas and expressions of opinion made in the articles are the personal opinion and assumption of MaiMarFX traders. They are not meant to be a solicitation or recommendation to buy or sell a specific financial instrument.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.